Covid-19 roundup: Russian biotech seeks permission to produce remdesivir generic; Why did BARDA fund plasma company part-owned by Rick Santorum?
Russian biotech Pharmasyntez is turning to the Kremlin for a way around Gilead’s patent on remdesivir, Reuters reported.
The company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
